Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Ideaya Biosciences Inc
(NQ:
IDYA
)
26.79
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Ideaya Biosciences Inc
< Previous
1
2
3
4
5
Next >
Why Ideaya Biosciences Stock Is Plummeting Today
October 25, 2023
Ideaya stock is getting hit hard following a recent press release from the company.
Via
The Motley Fool
Why IDEAYA Biosciences Stock Is Falling During Wednesday's Session
October 25, 2023
Ideaya Biosciences Inc (NASDAQ: IDYA) shares are trading lower by 11.6% to $24.10 Wednesday morning after the company priced an underwritten public offering of common stock and pre-funded warrants.
Via
Benzinga
Alphabet, Texas Instruments, CoStar Group And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
October 25, 2023
U.S. stock futures traded mixed this morning on Wednesday. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
Where IDEAYA Biosciences Stands With Analysts
October 11, 2023
Via
Benzinga
7 Analysts Have This to Say About IDEAYA Biosciences
September 12, 2023
Via
Benzinga
Adobe To Rally Over 14%? Here Are 10 Other Analyst Forecasts For Tuesday
September 12, 2023
RBC Capital boosted the price target for CareTrust REIT, Inc. (NYSE: CTRE) from $19 to $23. RBC Capital analyst Michael Carroll upgraded the stock from Sector Perform to Outperform. CareTrust REIT...
Via
Benzinga
The Latest Analyst Ratings for IDEAYA Biosciences
August 11, 2023
Via
Benzinga
Analyst Expectations for IDEAYA Biosciences's Future
May 24, 2023
Via
Benzinga
Top 5 Health Care Stocks That May Fall Off A Cliff
September 06, 2023
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
Via
Benzinga
Akamai Technologies, Array Technologies Music, HNI, PENN Entertainment And Other Big Stocks Moving Higher On Wednesday
August 09, 2023
U.S. stocks traded lower, with the Nasdaq Composite falling around 100 points on Wednesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2023
August 08, 2023
Via
Benzinga
Ideaya Biosciences Inc. (NASDAQ: IDYA) is a Stock Spotlight on 5/11
May 11, 2023
Via
Investor Brand Network
Recap: IDEAYA Biosciences Q1 Earnings
May 09, 2023
IDEAYA Biosciences (NASDAQ:IDYA) reported its Q1 earnings results on Tuesday, May 9, 2023 at 06:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Top 5 Health Care Stocks That Could Sink Your Portfolio This Quarter
June 06, 2023
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 24, 2023
May 24, 2023
Via
Benzinga
IDEAYA Biosciences: Q1 Earnings Insights
May 09, 2023
IDEAYA Biosciences (NASDAQ:IDYA) reported its Q1 earnings results on Tuesday, May 9, 2023 at 06:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
April 24, 2023
Via
Benzinga
IDEAYA Biosciences Inc. (NASDAQ: IDYA) Leading the Way in Monday Trading Based on Percentage Gain
April 24, 2023
Via
Investor Brand Network
IDEAYA Biosciences's Return On Capital Employed Insights
March 09, 2023
Via
Benzinga
Why IDEAYA Biosciences Shares Are Trading Higher By Around 27%? Here Are Other Stocks Moving In Monday's Mid-Day Session
April 24, 2023
Gainers Aclarion, Inc. (NASDAQ: ACON) shares surged 152% to $1.85 amid the publication of durability data for the company's back pain treatment.
Via
Benzinga
Nasdaq Turns Lower Ahead Of Big Week For Tech
April 24, 2023
The Nasdaq Composite Index has begun to slip deeper into the red ahead of this week's slew of Big Tech earnings.
Via
Talk Markets
IDEAYA Biosciences Touts Encouraging Data From Combo Therapy For Rare Eye Cancer Impacting Around 14,000 In US and Europe
April 24, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 28, 2022
December 28, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 24, 2023
April 24, 2023
Via
Benzinga
US Stocks Edge Higher; Coca-Cola Posts Upbeat Results
April 24, 2023
U.S. stocks traded slightly higher this morning, with the Dow Jones gaining around 30 points on Monday. Following the market opening Monday, the Dow traded up 0.10% to 33,843.10 while the NASDAQ rose...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 24, 2023
Via
Benzinga
Philips, Credit Suisse And Other Big Stocks Moving Higher In Monday's Pre-Market Session
April 24, 2023
U.S. stock futures traded lower this morning. Here are some big stocks recording gains in today’s pre-market trading session.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 23, 2023
March 23, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 28, 2023
February 28, 2023
Via
Benzinga
Buy/Sell: Wall Street's Top 5 Stock Calls This Week - Sunday, Jan. 1
January 01, 2023
What was Wall Street buzzing about this past week? Let's take a closer look at the top 5 buy calls made by Wall Street’s best analysts during the week of Dec. 26-30, 2022.
Via
Talk Markets
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.